Clinical Trials
232 trialsBYQoL-GC
Assistance Publique - Hôpitaux de Paris
VITaL
University of Sydney
Tumor HI
Rezolute
ULTIMO
Cancer Research Antwerp
EAST-ALIGN
National Cancer Centre, Singapore
NOVEL
Imperial College London
EMBRAIN
Odense University Hospital
AspiRe HCC
Curtin University
PREVENT HPV -Related Cancers Trial
University of Utah
MorphinOgel
University Hospital, Strasbourg, France
PRIMARY2
Peter MacCallum Cancer Centre, Australia
PARASTOP
Oslo University Hospital
DéPOH
Institut Paoli-Calmettes
Lenalidomide, Bortezomib and Dexamethasone Induction Therapy With Either Intravenous or Subcutaneous Isatuximab in Patients With Newly Diagnosed Multiple Myeloma
University of Heidelberg Medical Center
DOAC
University of Vermont
FRUQUITAS
Federation Francophone de Cancerologie Digestive
TRIPLEX
Norwegian University of Science and Technology
Adjuvant Oxaliplatin Plus S-1 Versus Docetaxel Plus S-1 for Stage III Gastric Cancer
Ruijin Hospital
A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients
M.D. Anderson Cancer Center
SPC
The Methodist Hospital Research Institute
Glutamine for the Prophylaxis of Vincristine-induced Neuropathy in Children and Adolescents With Cancer.
Ain Shams University
Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients
University of California, San Diego
IROCAS
UNICANCER
Promoting Breast Cancer Screening in Women Who Survived Childhood Cancer
Memorial Sloan Kettering Cancer Center
VITAL
Brigham and Women's Hospital
MATCH
University of Texas Southwestern Medical Center
HERO
Fudan University
ATRIUM
Massachusetts General Hospital
FIDURA
Sahlgrenska University Hospital
Pre-operative SRS or Post-operative SRS in Treating Cancer Patients With Brain Metastases
M.D. Anderson Cancer Center
MENAC
Norwegian University of Science and Technology
TEMPO-MIBC
University of Rome Tor Vergata
OSCAR
Federation Francophone de Cancerologie Digestive
TRIM-Line
Ottawa Hospital Research Institute
Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cancer Operations (PRS II)
Fox Chase Cancer Center
PROStep
Abramson Cancer Center at Penn Medicine
Olanzapine for Prevention of Vomiting in Children and Adolescents Receiving Highly Emetogenic Chemotherapy
Shanghai Children's Medical Center
Néofirinox
UNICANCER
Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours
University College, London
UMBRELLA
Gustave Roussy, Cancer Campus, Grand Paris
AtTEnd
Mario Negri Institute for Pharmacological Research
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Alliance for Clinical Trials in Oncology
BRCA-P
Alliance for Clinical Trials in Oncology
Efficacy of Auricular Pressure Beans with Electroacupuncture and Estazolam Treating Insomnia Caused by Cancer
Qinghai Red Cross Hospital
PRIME
University of Aarhus
EURTAC
Spanish Lung Cancer Group
A Prospective Clinical Cohort Study on Stratified Treatment of Rhabdomyosarcoma Based on Risk Factors.
Sun Yat-sen University
API-CAT
Assistance Publique - Hôpitaux de Paris
MIST
Alliance for Clinical Trials in Oncology
PANTHER
Karolinska University Hospital